August 14, 2022
Your browser doesn’t improve HTML5 audio On Thursday, Yuanhua Clever Generation (Shenzhen) Co., Ltd. (Yuanhua

Your browser doesn’t improve HTML5 audio

On Thursday, Yuanhua Clever Generation (Shenzhen) Co., Ltd. (Yuanhua Tech) finished a round-B financing price a number of hundred million yuan. The main investor is Costone Capital, whilst present shareholders Shenzhen Capital Team Co., Ltd. and Sequoia China joined within the financing. Different co-investors come with a number of famed funding establishments reminiscent of Money Capital and Wanhui Capital.

Yuanhua Tech used to be established in December 2018. Located as an leading edge high-tech endeavor, it makes a speciality of specialised surgical robots throughout a spread of scientific departments. In March 2021, it finished round-A financing of 200 million yuan ($31.53 million), with Sequoia China and CMB World as main buyers, and its former shareholder Shenzhen Capital Team Co., Ltd. and Hotland Clinical Asset Control as co-investors.

The finances are for use for the entire industrial utility of orthopedic surgical robots, to boost up the scientific development of digestive tract merchandise and surgical robots via herbal lumens, and to advertise the overall take a look at and industrial utility of the self-developed cooperative mechanical arm.

Gusheng Yuanhua Robotic (Shenzhen) Co., Ltd. is a wholly-owned subsidiary of Yuanhua Tech, and is outstanding for the main general orthopedic surgical treatment auxiliary robotic gadget. The program may help docs to finish quite a lot of orthopedic operations reminiscent of knee or hip replacements, trauma and spinal procedures.

In January, 2022, general hip substitute assisted through Gusheng Yuanhua began scientific utility, and a multicenter randomized managed scientific trial used to be collectively performed through 5 hospitals together with First Clinical Middle of the Normal Health facility of the Folks’s Liberation Military (PLAGH) and West China Health facility, Sichuan College.

See also  Singaporean Tech Company Sea Pledges E-Trade Expansion in 2022

SEE ALSO: AI Chip Maker Axera Secures $126 Million in A++ Financing Spherical

When it comes to product line, Yuanhua Tech has finished the improvement of digestive tract merchandise and herbal hollow space surgical treatment robots, will quickly end preclinical analysis, and can put them into scientific verification.

Relating to core elements, Yuanhua Tech has implemented the primary era of self-developed navigation schemes in product registration. As well as, it has finished the overall take a look at of a brand new era of independently-developed navigation apparatus and a cooperative manipulator specifically designed for orthopedic surgical treatment, and can put them into use inside this yr.